WILLIAM A. JONES JR

Insider Reports History

Location
Lexington, MA
Signature
/s/ Matthew Batters, as attorney-in-fact for William Jones
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by WILLIAM A. JONES JR:

Company Role Class Num Shares Value Price $ Report Date Ownership
NewAmsterdam Pharma Co N.V. Chief Commercial Officer Ordinary Shares 43,000 $1,098,087 $25.54 07 Jan 2025 Direct
NewAmsterdam Pharma Co N.V. Chief Commercial Officer Option (right to buy) 200,000 02 Jan 2025 Direct
Annexon, Inc. Director Stock Option (Right to Buy) 55,000 05 Jun 2025 Direct
Akili, Inc. Director Stock Option (Right to Buy) 22,000 02 May 2023 Direct
Apogee Therapeutics, Inc. Director Stock Option (Right to Buy) 14,461 17 Jun 2025 Direct
Biohaven Pharmaceutical Holding Co Ltd. CCO-Migraine & Common Disease Common Shares 0 $148.50 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. CCO-Migraine & Common Disease Restricted Share Unit Award 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. CCO-Migraine & Common Disease Stock Options (Right to Buy) 0 03 Oct 2022 Direct

Insider Reports Filed by WILLIAM A. JONES JR

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APGE Apogee Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 20 Jun 2025, 20:03
ANNX Annexon, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:17
ANNX Annexon, Inc. 09 Jan 2025 1 $0 4 Director 10 Jan 2025, 18:02
ANNX Annexon, Inc. 09 Jan 2025 0 $0 3 Director 10 Jan 2025, 18:00
NAMS NewAmsterdam Pharma Co N.V. 07 Jan 2025 1 $0 4 Chief Commercial Officer 07 Jan 2025, 17:12
NAMS NewAmsterdam Pharma Co N.V. 02 Jan 2025 1 $0 4 Chief Commercial Officer 06 Jan 2025, 17:51
APGE Apogee Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 20:12
NAMS NewAmsterdam Pharma Co N.V. 25 Apr 2024 0 $0 3 Chief Commercial Officer 03 May 2024, 16:15
APGE Apogee Therapeutics, Inc. 13 Jul 2023 0 $0 3/A Director 17 Jul 2023, 16:59
/report/000089924323012262-jones-william-a-jr-2023-05-02 Akili, Inc. 02 May 2023 1 $0 4 Director 04 May 2023, 16:20
/report/000089924322035242-jones-william-a-jr-2022-11-02 Akili, Inc. 02 Nov 2022 1 $0 4 Director 04 Nov 2022, 18:58
/report/000156218022006962-jones-william-a-jr-2022-10-03 Biohaven Pharmaceutical Holding Co Ltd. 03 Oct 2022 12 -$2,112,561 4 CCO-Migraine & Common Disease 03 Oct 2022, 20:25
/report/000089924322029345-jones-william-a-jr-2022-08-19 Akili, Inc. 19 Aug 2022 0 $0 3 Director 19 Aug 2022, 19:12
/report/000156218022000351-jones-william-a-jr-2022-01-06 Biohaven Pharmaceutical Holding Co Ltd. 06 Jan 2022 8 -$486,395 4 CCO-Migraine & Common Disease 07 Jan 2022, 20:16
/report/000156218021007302-jones-william-a-jr-2021-11-25 Biohaven Pharmaceutical Holding Co Ltd. 25 Nov 2021 3 -$150,793 4 CCO-Migraine & Common Disease 26 Nov 2021, 15:32